MIMS news

Two new glaucoma preparations in preservative-free multi-dose bottles

Two new glaucoma preparations in preservative-free multi-dose bottles

Eydelto (dorzolamide) and Eylamdo (dorzolamide/timolol)...

First oral short-course treatment for MS

First oral short-course treatment for MS

Mavenclad (cladribine) is licensed for the treatment...

Epilepsy treatment now available as licensed medicine

Epilepsy treatment now available as licensed medicine

Epistatus (midazolam), previously classified as an...

New MIMS workshop announced: 'Why smoking cessation is everyone's problem'

New MIMS workshop announced: 'Why smoking cessation is everyone's problem'

A free half-day MIMS workshop has been announced for...

NICE approval for new psoriasis tablet

NICE approval for new psoriasis tablet

Dimethyl fumarate (Skilarence) is now an option for...

Topical psoriasis treatment to be available without a prescription

Topical psoriasis treatment to be available without a prescription

Patients with psoriasis will be able to buy Dovonex...

Flu vaccines for 2017/18 season

Flu vaccines for 2017/18 season

Vaccines for the 2017/18 flu season are expected to...

MIMS publishes supplement on cow's milk allergy

MIMS publishes supplement on cow's milk allergy

MIMS readers will be receiving a special supplement...

'No evidence of patient safety risk' with controversial sterilisation device, says MHRA

'No evidence of patient safety risk' with controversial sterilisation device, says MHRA

The MHRA has advised women who have undergone hysteroscopic...

NICE approves first treatment for IBS with diarrhoea

NICE approves first treatment for IBS with diarrhoea

Eluxadoline (Truberzi) can now be prescribed routinely...

Stopping statins after stroke linked to higher risk of recurrent stroke

Stopping statins after stroke linked to higher risk of recurrent stroke

Patients who stop statin therapy 3 to 6 months after...

Arthritis treatment options widened with launch of anti-IL-6 antibody

Arthritis treatment options widened with launch of anti-IL-6 antibody

Sarilumab (Kevzara) is a new biologic treatment for...

MHRA updates adrenaline pen prescribing guidance

MHRA updates adrenaline pen prescribing guidance

GPs should prescribe two adrenaline auto-injectors...

New antiviral for all major hepatitis C genotypes

New antiviral for all major hepatitis C genotypes

Maviret is a fixed-dose combination of two direct-acting...

Warn patients to report visual disturbances during steroid treatment, GPs advised

Warn patients to report visual disturbances during steroid treatment, GPs advised

Central serous chorioretinopathy (CSCR) is a retinal...

Temporary hepatitis B vaccination recommendations issued in light of vaccine shortages

Temporary hepatitis B vaccination recommendations issued in light of vaccine shortages

Global shortages of hepatitis B vaccines, including...

New class of rheumatoid arthritis treatment approved for NHS use

New class of rheumatoid arthritis treatment approved for NHS use

NICE has approved use of the JAK inhibitor baricitinib...

NICE updates guidance on use of bisphosphonates in osteoporosis

NICE updates guidance on use of bisphosphonates in osteoporosis

The new guidance supersedes parts of earlier guidance...

Fumaric acid ester now available as licensed oral psoriasis treatment

Fumaric acid ester now available as licensed oral psoriasis treatment

Prescribers treating patients with moderate to severe...

First triple combination inhaler launched for COPD

First triple combination inhaler launched for COPD

Trimbow is a 3-in-1 treatment for chronic obstructive...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases